Trial · NCT03696121
Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
NCT03696121, Phase 2, Completed, University of Nottingham
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage. Trials, record NCT03696121. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03696121
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Desmopressin for Reversal of Antiplatelet Drugs in Stroke Due to Haemorrhage
- NCT number
- NCT03696121
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 54 participants, actual
- Lead sponsor
- University of Nottingham
- Conditions
- Stroke, Acute
- Interventions
- Desmopressin Injection, Normal saline
- First posted
- 2018-10-04
- Last updated
- 2022-11-15
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of eligible patients who received allocated treatment | 90 days | Number - higher number indicates feasibility of trial |
| Primary | Rate of eligible patients randomised | 18 months | Shorter period of time to recruit number of patients indicates trial is feasibility;e |
| Primary | Proportion of eligible patients and randomised | 18 months | Are there sufficient numbers of patients to justify a larger trial |
| Primary | Proportion of participants followed up at 90 days | 90 days | Higher number indicates feasibility |
| Primary | Proportion of patients with full outcome data available, and reasons for non-availability | 90 days | Higher number indicates feasibility |
| Primary | Proportion of eligible patients approached | 18 months | Higher number indicates feasibility |
| Primary | Adherence to intervention | 18 months | Higher number indicates feasibility |
| Secondary | Death or dependency at 90 days | 18 months | Lower number indicates positive outcome |
| Secondary | Number of patients dead or suffered serious adverse events | Day 28 and 90 | Number - higher number indicates worse outcome |
| Secondary | Change in intracerebral haemorrhage volume at 24 hours | 24 hours | Higher volume indicates worse outcome |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03696121
GET https://conductscience.org/api/trials/v1/NCT03696121/registered